Inventor · disambiguated record
Kimihisa Ichikawa
Also filed as: ICHIKAWA KIMIHISA
13 granted patents·9 pending applications·144 citations·filing 2000–2015
92Inventor score
Files withSANKYO CO5UAB RESEARCH FOUNDATION5DAIICHI SANKYO CO LTD4CHIBA YASUNORI2SEATTLE GENETICS INC2
Top patents by PatentIndex Score
22 records- 0190US7704502B2Combinations of antibodies selective for DR5 and other therapeutic agentsUAB RESEARCH FOUNDATION·Filed 2007·Granted Apr 27, 2010·14 cites·70 claims
- 0290US7244429B2Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereofUAB RESEARCH FOUNDATION·Filed 2001·Granted Jul 17, 2007·26 cites·107 claims
- 0389US7981421B2Combinations of antibodies selective for DR5 and other therapeutic agentsUAB RESEARCH FOUNDATION·Filed 2010·Granted Jul 19, 2011·13 cites·58 claims
- 0489US7790165B2Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereofUAB RESEARCH FOUNDATION·Filed 2007·Granted Sep 7, 2010·10 cites·65 claims
- 0589US6972323B1Anti-Fas antibodiesSANKYO CO·Filed 2000·Granted Dec 6, 2005·28 cites·36 claims
- 0688US8409825B2Method for high-level secretory production of proteinCHIBA YASUNORI·Filed 2008·Granted Apr 2, 2013·17 cites·27 claims
- 0786US7279160B2Combinations of DR5 antibodies and other therapeutic agentsUAB RESEARCH FOUNDATION·Filed 2002·Granted Oct 9, 2007·24 cites·65 claims
- 0880US8232377B2Method for high-level secretory production of proteinCHIBA YASUNORI·Filed 2007·Granted Jul 31, 2012·4 cites·32 claims
- 0978US8715668B2Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereofZHOU TONG·Filed 2012·Granted May 6, 2014·2 cites·28 claims
- 1078US8329180B2Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereofZHOU TONG·Filed 2011·Granted Dec 11, 2012·2 cites·19 claims
- 1174US9700618B2Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereofUAB RES FOUND·Filed 2014·Granted Jul 11, 2017·1 cites·23 claims
- 1264US7855056B2Antibody against tumor specific antigen as targetSANKYO CO·Filed 2004·Granted Dec 21, 2010·1 cites·3 claims
- 1363US6746673B2Pharmaceutical compositions containing anti-Fas antibodySANKYO CO·Filed 2001·Granted Jun 8, 2004·2 cites·14 claims
- 1458US2015079114A1Dr5 ligand drug conjugatesSEATTLE GENETICS INC·Filed 2013·Application pending·0 cites
- 1557US2003170817A1Anti-Fas antibodiesSANKYO CO·Filed 2003·Application pending·0 cites
- 1657US2013280282A1Dr5 ligand drug conjugatesDAIICHI SANKYO CO LTD·Filed 2013·Application pending·0 cites
- 1756US2010209490A1Immunoliposome inducing apoptosis into cell expressing death domain-containing receptorDAIICHI SANKYO CO LTD·Filed 2008·Application pending·0 cites
- 1856US2007025996A1Oculospanin as a tumor specific antigen and methods and compositions utilizing sameICHIKAWA KIMIHISA·Filed 2006·Application pending·0 cites
- 1956US2011269942A1Antibodies modified with hydrophobic moleculeDAIICHI SANKYO CO LTD·Filed 2008·Application pending·0 cites
- 2055US2003103976A1Anti-fas antibodiesSANKYO CO·Filed 2002·Application pending·0 cites
- 2140US2011070248A1Dr5 ligand drug conjugatesSEATTLE GENETICS INC·Filed 2010·Application pending·0 cites
- 2235US2017211063A1Method for improved high-level secretory production of proteinDAIICHI SANKYO CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kimihisa Ichikawa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →